Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$340K Sell
6,794
-304
-4% -$14.6K 0.5% 68
2025
Q3
$348K Sell
7,098
-181
-2% -$9.28K 0.36% 70
2025
Q2
$377K Hold
7,279
0.39% 66
2025
Q1
$340K Sell
7,279
-38
-0.5% -$1.96K 0.35% 65
2024
Q4
$375K Buy
7,317
+24
+0.3% +$1.24K 0.36% 63
2024
Q3
$324K Hold
7,293
0.3% 68
2024
Q2
$293K Sell
7,293
-1,124
-13% -$42.6K 0.31% 66
2024
Q1
$337K Hold
8,417
0.32% 75
2023
Q4
$317K Buy
+8,417
New +$257K 0.31% 78

Other funds holding SNV

QSV Equity Investors's SNV Position: Q4 2025 in Review

QSV Equity Investors reduced its Synovus (SNV) stake by 4.3% in Q4 2025, selling an estimated $14.6K and leaving 6,794 shares worth $340K. The position accounts for 0.5% of the portfolio, ranked #68.

QSV Equity Investors first reported a position in SNV in Q4 2023 and has held it in 9 quarters since. The position peaked at $377K in Q2 2025. 452 funds tracked by Wall St. Rank hold SNV as of Q4 2025.

  • QSV Equity Investors held 6,794 shares of Synovus worth $340K as of Q4 2025.
  • QSV Equity Investors sold 304 Synovus shares in Q4 2025, an estimated $14.6K.
  • Synovus made up 0.5% of QSV Equity Investors's portfolio in Q4 2025, its #68 holding.
  • QSV Equity Investors first reported a position in Synovus in Q4 2023 and has held it in 9 quarters since.
  • QSV Equity Investors's Synovus position peaked at $377K in Q2 2025.
  • 452 funds tracked by Wall St. Rank held Synovus as of Q4 2025.

Based on QSV Equity Investors's 13F filing for Q4 2025, filed 12 Feb 2026.